Q96RI1 |
NR1H4_HUMAN |
Autoimmune liver disease [ICD-11: DB96] |
Q96RI1 |
NR1H4_HUMAN |
Cholelithiasis [ICD-11: DC11] |
Q96RI1 |
NR1H4_HUMAN |
Insomnia [ICD-11: 7A00-7A0Z] |
Q96RI1 |
NR1H4_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
Q96RI1 |
NR1H4_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96RI1 |
NR1H4_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q96RI1 |
NR1H4_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
Q96RI1 |
NR1H4_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
Q96RI1 |
NR1H4_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q96RI1 |
NR1H4_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q96RI1 |
NR1H4_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P02768 |
ALBU_HUMAN |
Aneurysm/dissection [ICD-11: BD50] |
P02768 |
ALBU_HUMAN |
Bowel habit change [ICD-11: ME05] |
P02768 |
ALBU_HUMAN |
Cholelithiasis [ICD-11: DC11] |
P02768 |
ALBU_HUMAN |
Inborn energy metabolism error [ICD-11: 5C53] |
P02768 |
ALBU_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
P02768 |
ALBU_HUMAN |
Preprocedural examination [ICD-11: QA0B] |
P02768 |
ALBU_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P02768 |
ALBU_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P02768 |
ALBU_HUMAN |
Unspecific body region injury [ICD-11: ND56] |
P02768 |
ALBU_HUMAN |
Coagulation defect [ICD-11: 3B10] |
P02768 |
ALBU_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P02768 |
ALBU_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
Q8TDU6 |
GPBAR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 |
GPBAR_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q8TDU6 |
GPBAR_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |